Press Release | NeoGenomics Laboratories

February 21, 2018

NeoGenomics Reports Revenue of $67.8 Million on 18.7% Clinical Volume Growth and $10.5 Million of Adjusted EBITDA in the Fourth Quarter of 2017

January 30, 2018

NeoGenomics Schedules its Fourth Quarter and Fiscal Year 2017 Earnings Release for February 21, 2018

December 6, 2017

NeoGenomics Announces Six Clinical Data Presentations to be Made at the American Society of Hematology Meeting

December 5, 2017

NeoGenomics Joins Thermo Fisher Scientific's Companion Diagnostic Center of Excellence Program with the Launch of Oncomine Dx Target Test

November 9, 2017

NeoGenomics Europe S.A. Opens its Doors in Rolle, Switzerland Laboratory Hosting Business Leaders, Dignitaries and Local Government Officials

October 24, 2017

NeoGenomics Announces the Opening of its First International Laboratory near Geneva, Switzerland to Support Clinical Trials

October 24, 2017

NeoGenomics Reports Revenue of $63.1 Million on 17% Volume Growth and 11% Reduction in Average Cost per Test in the Third Quarter of 2017

October 12, 2017

NeoGenomics Announces Preliminary Quarter 3 Results, Financial Impacts of Hurricanes and Summary Quarter 4 Guidance

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients